French continue moves to cut reimbursement abuse
This article was originally published in Clinica
The French government is expanding its TIPS reimbursement list to cover more implantable medical devices as part of a move to counteract invoicing abuse. The move to increase and regulate the TIPS list began after a series of violations in the mid 1990s when revelations of companies selling orthopaedic prostheses in excess of the fixed price led to some 20 companies being closed.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.